ArticleJCO global oncology2020
Teleoncology: The Youngest Pillar of Oncology.
Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The safety and acceptability of using telehealth for follow-up of patients following cancer surgery: A systematic review.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2023Pooled it
- Determinants of the implementation of eHealth-based long-term follow-up care for young cancer survivors: a qualitative study.BMC cancer · 2024Article
- KIT 1 (Keep in Touch) Project-Televisits for Cancer Patients during Italian Lockdown for COVID-19 Pandemic: The Real-World Experience of Establishing a Telemedicine System.Healthcare (Basel, Switzerland) · 2023Article
- Telemedicine Adoption in an NCI-Designated Cancer Center During the COVID-19 Pandemic: A Report on Patient Experience of Care.Journal of the National Comprehensive Cancer Network : JNCCN · 2023Article
- Adolescent and Young Adult Survivorship Care: Emerging from the COVID-19 Pandemic Stronger Through Teleoncology.Journal of adolescent and young adult oncology · 2023Review
- Remote Monitoring of Colorectal Cancer Survivors Using a Smartphone App and Internet of Things-Based Device: Development and Usability Study.JMIR cancer · 2023Article
- Telehealth in breast cancer following the coronavirus disease 2019 pandemic.Exploration of targeted anti-tumor therapy · 2023Review
- Providing geriatric oncology care using telemedicine for older patients with cancer during the COVID-19 pandemic in Mexico.Ecancermedicalscience · 2023Article
- The potential of eHealth for cancer patients-does COVID-19 pandemic change the attitude towards use of telemedicine services?PloS one · 2023Article
- Article
- Patients' experience and satisfaction using telemedicine for outpatient services in a Tertiary Cancer Center in Qatar during COVID-19: A cross-sectional study.Health science reports · 2022Article
- The Potential Role of Telemedicine in Early Detection of Oral Cancer: A Literature Review.Journal of pharmacy & bioallied sciences · 2022Review
- Health Care Providers' and Professionals' Experiences With Telehealth Oncology Implementation During the COVID-19 Pandemic: A Qualitative Study.Journal of medical Internet research · 2022Article
- Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine.Cancer management and research · 2022Article
- COVID-19 pandemic and lock-down protocols: Impact in an indian tertiary cancer center.Oral oncology · 2022Article
- Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021Article
- The Utilization and Benefits of Telehealth Services by Health Care Professionals Managing Breast Cancer Patients during the COVID-19 Pandemic.Healthcare (Basel, Switzerland) · 2021Review
- Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward.Journal of the National Cancer Institute · 2021Article
- Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience.Mayo Clinic proceedings. Innovations, quality & outcomes · 2021Article
- Continuing cancer surgery through the first six months of the COVID-19 pandemic at an academic university hospital in India: A lower-middle-income country experience.Journal of surgical oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The core pillars of multimodal care of patients with cancer are surgical, radiation, and medical oncology. The global pandemic of coronavirus disease 2019 (COVID-19) has suddenly resurrected a new pillar in oncology care: teleoncology. With oncologists reaching out to patients through telemedicine, it is possible to evaluate and fulfill patients' needs; triage patients for elective procedures; screen them for influenza-like illness; provide them with guidance for hospital visits, if needed; and bridge oral medications and treatments when a hospital visit is not desirable because of any high risk-benefit ratio. Teleoncology can bring great reassurance to patients at times when reaching an oncology center is challenging, and more so in resource-constrained countries. Evidence-based treatment protocols, dispensable by teleoncology, already exist for many sites of cancer and they can provide a bridge to treatment when patients are unable to reach cancer centers for their standard treatment. The young pillar of teleoncology is going to remain much longer than COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.